These comprehensive investigations of genetic alterations underlying MPN have revealed that additional somatic mutations co-occur with the driver mutations in JAK2, CALR, and MPL genes in more than half of MPN patients [11,33,44]. Here, JAK2 is linked to myeloproliferative neoplasm.